Candel Therapeutics, Inc.
SEC Filing List
CADL CIK: 0001841387
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Candel Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |
| SCHEDULE 13G | 05/15/2026 | ||||
| 8-K | Current report filing | Candel Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/14/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Candel Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/14/2026 | |
| DEF 14A | Definitive proxy statements | Candel Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/29/2026 | |
| ARS | Annual report to security holders | Candel Therapeutics, Inc. | 04/29/2026 | ||
| DEFA14A | Definitive additional proxy soliciting m... | Candel Therapeutics, Inc. | 04/29/2026 | ||
| SCHEDULE 13G/A | 04/27/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Manning Paul B | Candel Therapeutics, Inc. | 04/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Papa Joseph C | Candel Therapeutics, Inc. | 04/02/2026 | |
| No record found. | |||||
| Load More | |||||
